SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,033.78 1,109.10
( 1.54%)

Global Indices

Nasdaq

51,875.59 199.64
(0.39%)

Dow Jones

7,829.18 -3.36
(-0.04%)

Hang Seng

67,705.85 -1,325.07
(-1.92%)

Nikkei 225

10,644.02 91.97
(0.87%)

Forex

USD-INR

96.46 -0.32
(-0.33%)

EUR-INR

108.04 -0.35
(-0.32%)

GBP-INR

127.62 -0.24
(-0.19%)

JPY-INR

0.61 0.00
(-0.50%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

45.53

1098.39

EPS(TTM)

Face Value()

Div & Yield %

20.47

0.05

Back

radhagobind commercial ltd

Titan Biotech consolidated net profit rises 58.31% in the June 2026 quarter

Aug 14,2026

Net profit of Titan Biotech rose 58.31% to Rs 10.86 crore in the quarter ended June 2026 as against Rs 6.86 crore during the previous quarter ended June 2025. Sales rose 27.25% to Rs 59.17 crore in the quarter ended June 2026 as against Rs 46.50 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	59.17	46.50	27
OPM %	21.11	18.80	-
PBDT	14.10	9.26	52
PBT	12.73	8.11	57
NP	10.86	6.86	58

73,033.78 1,109.10 ( 1.54%)

51,875.59 199.64 (0.39%)

7,829.18 -3.36 (-0.04%)

67,705.85 -1,325.07 (-1.92%)

10,644.02 91.97 (0.87%)

96.46 -0.32 (-0.33%)

108.04 -0.35 (-0.32%)

127.62 -0.24 (-0.19%)

0.61 0.00 (-0.50%)